• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用对比变分自动编码器揭示阿尔茨海默病各阶段的神经基础。

Uncovering neural substrates across Alzheimer's disease stages using contrastive variational autoencoder.

机构信息

School of Electronic Information, Central South University, Changsha, 410148, China.

School of Computer Science and Engineering, Central South University, Changsha, 410083, China.

出版信息

Cereb Cortex. 2024 Oct 3;34(10). doi: 10.1093/cercor/bhae393.

DOI:10.1093/cercor/bhae393
PMID:39363728
Abstract

Alzheimer's disease is the most common major neurocognitive disorder. Although currently, no cure exists, understanding the neurobiological substrate underlying Alzheimer's disease progression will facilitate early diagnosis and treatment, slow disease progression, and improve prognosis. In this study, we aimed to understand the morphological changes underlying Alzheimer's disease progression using structural magnetic resonance imaging data from cognitively normal individuals, individuals with mild cognitive impairment, and Alzheimer's disease via a contrastive variational autoencoder model. We used contrastive variational autoencoder to generate synthetic data to boost the downstream classification performance. Due to the ability to parse out the nonclinical factors such as age and gender, contrastive variational autoencoder facilitated a purer comparison between different Alzheimer's disease stages to identify the pathological changes specific to Alzheimer's disease progression. We showed that brain morphological changes across Alzheimer's disease stages were significantly associated with individuals' neurofilament light chain concentration, a potential biomarker for Alzheimer's disease, highlighting the biological plausibility of our results.

摘要

阿尔茨海默病是最常见的主要神经认知障碍。虽然目前尚无治愈方法,但了解阿尔茨海默病进展的神经生物学基础将有助于早期诊断和治疗,减缓疾病进展,改善预后。在这项研究中,我们旨在使用认知正常个体、轻度认知障碍个体和阿尔茨海默病患者的结构磁共振成像数据,通过对比变分自动编码器模型来了解阿尔茨海默病进展的形态学变化。我们使用对比变分自动编码器生成合成数据来提高下游分类性能。由于能够解析出年龄和性别等非临床因素,对比变分自动编码器促进了不同阿尔茨海默病阶段之间更纯粹的比较,以确定与阿尔茨海默病进展相关的特定病理变化。我们表明,阿尔茨海默病各阶段的大脑形态变化与个体的神经丝轻链浓度显著相关,神经丝轻链浓度是阿尔茨海默病的潜在生物标志物,这突出了我们结果的生物学合理性。

相似文献

1
Uncovering neural substrates across Alzheimer's disease stages using contrastive variational autoencoder.利用对比变分自动编码器揭示阿尔茨海默病各阶段的神经基础。
Cereb Cortex. 2024 Oct 3;34(10). doi: 10.1093/cercor/bhae393.
2
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).(11)使用C-PIB-PET对轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆进行早期诊断。
Cochrane Database Syst Rev. 2014 Jul 23;2014(7):CD010386. doi: 10.1002/14651858.CD010386.pub2.
5
Change points for dynamic biomarkers in the Alzheimer's disease pathological cascade: A 30-year cohort study.阿尔茨海默病病理级联中动态生物标志物的变化点:一项30年队列研究。
Alzheimers Dement. 2025 Aug;21(8):e70544. doi: 10.1002/alz.70544.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
A machine learning approach for identifying anatomical biomarkers of early mild cognitive impairment.一种用于识别早期轻度认知障碍解剖生物标志物的机器学习方法。
PeerJ. 2024 Dec 13;12:e18490. doi: 10.7717/peerj.18490. eCollection 2024.
8
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
9
Age-Associated Cortical Thinning in Speech Motor Regions Precedes Hippocampal Decline: Implications for Alzheimer's Disease.言语运动区域与年龄相关的皮质变薄先于海马体衰退:对阿尔茨海默病的启示。
Hum Brain Mapp. 2025 Aug 1;46(11):e70288. doi: 10.1002/hbm.70288.
10
Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer's disease neuropathology.脑 MRI 年龄异质性与认知、遗传学及阿尔茨海默病神经病理学的关系。
EBioMedicine. 2024 Nov;109:105399. doi: 10.1016/j.ebiom.2024.105399. Epub 2024 Oct 21.

引用本文的文献

1
Understanding heterogeneity in psychiatric disorders: A method for identifying subtypes and parsing comorbidity.理解精神疾病中的异质性:一种识别亚型和解析共病的方法。
Psychiatry Clin Neurosci. 2025 Jul;79(7):406-414. doi: 10.1111/pcn.13829. Epub 2025 Apr 30.